Back to all blog posts
Aiforia, a leading provider of AI-powered solutions for digital pathology, has been honored with the Jacques Cresson Award, granted by the French Foreign Trade Advisors (Conseillers du Commerce Extérieur de la France – CCE). The award recognizes organizations for their significant contribution to strengthening France's international influence through innovation, global ambition, and tangible industry impact.
Recognition of global reach and commitment in France
The Jacques Cresson Award underscores Aiforia’s international success in delivering high-value AI solutions for digital pathology to hospitals and research centers worldwide. The recognition highlights our strong European origins and the growing presence in the French market.
Through its local subsidiary and dedicated team in France, Aiforia is actively contributing to the advancement of the French healthcare system. This commitment was recently demonstrated by key collaborations announced with leading French institutions, such as Assistance Publique–Hôpitaux de Paris (AP-HP), The Nantes University Hospital in France, and Institut Curie in France. These partners are deploying Aiforia's platform to enhance diagnostic accuracy and efficiency across pathology workflows.
Driving innovation with clinical and research solutions
Aiforia® Platform provides innovative and scalable AI solutions that address both clinical needs and advanced research demands:
- Aiforia’s clinical solutions: State-of-the-art, regulatory-approved AI models deployed to automate time-consuming analysis and standardize scoring in routine diagnostics, supporting pathologists in improving diagnostic precision and workflow efficiency.
- Aiforia® Create: A versatile, easy-to-use tool that empowers researchers and pathologists to develop, customize, and validate deep learning AI models for specialized research needs and translational medicine, accelerating scientific breakthroughs.
Aiforia's multi-organ AI solutions are designed for ease of implementation, allowing leading institutions on the global market to quickly realize improvements in efficiency and accuracy.
"Receiving the Jacques Cresson Award is a validation of our strategy to combine world-class AI innovation with local market impact," says Jukka Tapaninen, CEO of Aiforia. "This exciting milestone is a credit to the hard work and dedication of our teams, partners, and customers globally. It reinforces our ambition to drive the digital transformation of pathology and strengthen our presence in the French market."
Aiforia looks forward to leveraging this momentum to expand its reach further and continue developing powerful AI solutions for the global pathology market.
